[ACL] QoQ Quarter Result on 31-Dec-2023 [#Q2]

Stock
[ACL] Australian Clinical Labs Limited
Announcement Date
29-Dec-2023
Financial Year
2024
Quarter
31-Dec-2023 [#Q2]
Profit Trend
QoQ- 100.00%
YoY- -80.52%
Quarter Report
ACL's Result
ACL's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 179,550 179,550 333,719 168,634 336,760 168,380 360,312 -37.17%
PBT 14,280 14,280 7,806 3,903 15,554 7,777 32,756 -42.53%
Tax 4,696 4,696 2,731 1,366 4,994 2,497 7,274 -25.32%
NP 9,491 9,491 4,952 2,476 10,480 5,240 25,421 -48.18%
Tax Rate -32.88% -32.88% -34.99% -34.99% -32.11% -32.11% -22.21% -
Total Cost 170,059 170,059 328,767 166,158 326,280 163,140 334,891 -36.37%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 5.29 5.29 1.48 1.47 3.11 3.11 7.06 -17.51%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS 0.05 0.05 0.02 0.01 0.05 0.03 0.13 -47.14%
EPS Diluted 0.05 0.05 0.02 0.01 0.05 0.03 0.13 -47.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.